Multicenter study to evaluate paxalisib plus gemcitabine for children and young adults with recurrent or progressive AT/RT, where no approved therapies currently exist SYDNEY, Sept....
NEW YORK, April 10, 2025 /PRNewswire/ -- The Vietnamese ethanol production company, Vietnam Biofuels Development Joint Stock Company and its affiliates (together, "Vietnam Biofuels"...
DETROIT, April 10, 2025 /PRNewswire/ -- Creality, a leading global 3D printing technology brand, celebrated its 11th anniversary at the Renaissance Center of Detroit...
KIHEI, Hawaii, April 10, 2025 /PRNewswire/ -- Privateer, a leader in geospatial intelligence and space sustainability, today announced a strategic investment from Far Eastern...
Margin expansion from Hua Zang LLM MaaS and AI hardware sets the stage for sustainable earnings growth SHANGHAI, April 9, 2025 /PRNewswire/ -- Xiao‑I Corporation...